Proteinuria in Pre and Post Transplant

Last updated: November 20, 2025
Sponsor: University of Miami
Overall Status: Active - Recruiting

Phase

N/A

Condition

Nephrotic Syndrome

Proteinuria

Treatment

N/A

Clinical Study ID

NCT01094327
20070206
  • Ages < 25
  • All Genders

Study Summary

Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Kidney transplant recipients

  • Pediatric males and females up to the age of 25 years old.

Exclusion

Exclusion Criteria:

  • Transplant recipients other than kidney

Study Design

Total Participants: 100
Study Start date:
February 01, 2008
Estimated Completion Date:
November 30, 2026

Study Description

This study will retrospectively review patient's medical records for protein in the urine, blood creatinine and kidney biopsy results. Also character of the fluid used to flush the kidney before transplant will be analyzed.

Connect with a study center

  • University of Miami Miller School of Medicine Transplant Clinic

    Miami, Florida 33136
    United States

    Site Not Available

  • University of Miami Miller School of Medicine Transplant Clinic

    Miami 4164138, Florida 4155751 33136
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.